Report for: Pharmacotherapy for patellofemoral pain syndrome

Title	Pharmacotherapy for patellofemoral pain syndrome
Published in	Cochrane database of systematic reviews, July 2004
DOI	10.1002/14651858.cd003470.pub2
Pubmed ID	15266488
Authors	Edith M Heintjes, Marjolein Berger, Sita MA Bierma-Zeinstra, Roos MD Bernsen, Jan AN Verhaar, Bart W Koes
Abstract	Patellofemoral pain syndrome (PFPS) is common among adolescents and young adults. It is characterised by pain behind or around the patella and crepitations, provoked by ascending or descending stairs, squatting, prolonged sitting with flexed knees, running and cycling. The symptoms impede function in daily activities or sports. Pharmacological treatments focus on reducing pain symptoms (non-steroidal anti-inflammatory drugs (NSAIDs), glucocorticosteroids), or restoring the assumed underlying pathology (compounds containing glucosamine to stimulate cartilage metabolism, anabolic steroids to increase bone density of the patella and build up supporting muscles). In studies, drugs are usually applied in addition to exercises aimed at building up supporting musculature.

View on publisher site Alert me about new mentions

Mendeley readers

The data shown below were compiled from readership statistics for 266 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country	Count	As %
United Kingdom	2	<1%
United States	2	<1%
Spain	2	<1%
Brazil	1	<1%
Netherlands	1	<1%
Unknown	258	97%

Demographic breakdown

Readers by professional status	Count	As %
Student > Master	42	16%
Student > Bachelor	41	15%
Student > Ph. D. Student	31	12%
Researcher	18	7%
Student > Postgraduate	18	7%
Other	52	20%
Unknown	64	24%

Readers by discipline	Count	As %
Medicine and Dentistry	93	35%
Nursing and Health Professions	35	13%
Sports and Recreations	16	6%
Social Sciences	8	3%
Psychology	7	3%
Other	37	14%
Unknown	70	26%

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 January 2021.

All research outputs

#1,965,620

of 22,747,498 outputs

Outputs from Cochrane database of systematic reviews

#4,326

of 12,315 outputs

Outputs of similar age

#2,664

of 53,469 outputs

Outputs of similar age from Cochrane database of systematic reviews

of 37 outputs

Altmetric has tracked 22,747,498 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.

So far Altmetric has tracked 12,315 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.3. This one has gotten more attention than average, scoring higher than 64% of its peers.

Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 53,469 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.

We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.

Cochrane Database of Systematic Reviews

Pharmacotherapy for patellofemoral pain syndrome

About this Attention Score

Mentioned by

Citations

Readers on

Mendeley readers

Geographical breakdown

Demographic breakdown

Attention Score in Context